Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology and infection 2022-01, Vol.28 (1), p.1-5
Hauptverfasser:	Diallo, Alpha, Trøseid, Marius, Simensen, Victoria Charlotte, Boston, Anaïs, Demotes, Jacques, Olsen, Inge Christoffer, Chung, Florence, Paiva, José Artur, Hites, Maya, Ader, Florence, Arribas, Jose Ramon, Baratt-Due, Andreas, Melien, Øyvind, Tacconelli, Evelina, Staub, Thèrèse, Greil, Richard, Tsiodras, Sotirios, Briel, Matthias, Esperou, Hélène, Mentré, France, Eustace, Joe, Saillard, Juliette, Delmas, Christelle, LeMestre, Soizic, Dumousseaux, Marina, Costagliola, Dominique, Røttingen, John-Arne, Yazdanpanah, Yazdan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adaptive Clinical Trials as Topic COVID-19 EU-RESPOSE European Union Financial hurdles Government Regulation Human health and pathology Humans Legal hurdles Life Sciences Pandemics Platform trials Regulatory hurdles
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!